Annual Cash & Cash Equivalents
$19.13 M
-$867.00 K-4.34%
December 31, 2023
Summary
- As of February 7, 2025, NVCT annual cash & cash equivalents is $19.13 million, with the most recent change of -$867.00 thousand (-4.34%) on December 31, 2023.
- During the last 3 years, NVCT annual cash & cash equivalents has risen by +$19.13 million (+100.00%).
- NVCT annual cash & cash equivalents is now -4.34% below its all-time high of $19.99 million, reached on December 31, 2022.
Performance
NVCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$17.17 M
-$947.00 K-5.23%
September 30, 2024
Summary
- As of February 7, 2025, NVCT quarterly cash and cash equivalents is $17.17 million, with the most recent change of -$947.00 thousand (-5.23%) on September 30, 2024.
- Over the past year, NVCT quarterly cash and cash equivalents has dropped by -$4.89 million (-22.17%).
- NVCT quarterly cash and cash equivalents is now -30.21% below its all-time high of $24.60 million, reached on June 30, 2023.
Performance
NVCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NVCT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | -22.2% |
| 3 y3 years | +100.0% | -22.2% |
| 5 y5 years | +100.0% | -22.2% |
NVCT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | +233.1% | -30.2% | +199.0% |
| 5 y | 5-year | -4.3% | -100.0% | -30.2% | +199.0% |
| alltime | all time | -4.3% | -100.0% | -30.2% | +199.0% |
Nuvectis Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.17 M(-5.2%) |
| Jun 2024 | - | $18.12 M(-6.9%) |
| Mar 2024 | - | $19.46 M(+1.8%) |
| Dec 2023 | $19.13 M(-4.3%) | $19.13 M(-13.3%) |
| Sep 2023 | - | $22.06 M(-10.3%) |
| Jun 2023 | - | $24.60 M(+59.0%) |
| Mar 2023 | - | $15.47 M(-22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $19.99 M(+248.2%) | $19.99 M(-15.4%) |
| Sep 2022 | - | $23.64 M(+74.2%) |
| Jun 2022 | - | $13.57 M(-18.7%) |
| Mar 2022 | - | $16.69 M(+190.7%) |
| Dec 2021 | $5.74 M(>+9900.0%) | $5.74 M(-15.7%) |
| Sep 2021 | - | $6.81 M(-5.6%) |
| Jun 2021 | - | $7.21 M |
| Dec 2020 | $0.00 | - |
FAQ
- What is Nuvectis Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nuvectis Pharma?
- What is Nuvectis Pharma annual cash & cash equivalents year-on-year change?
- What is Nuvectis Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly cash and cash equivalents year-on-year change?
What is Nuvectis Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of NVCT is $19.13 M
What is the all time high annual cash & cash equivalents for Nuvectis Pharma?
Nuvectis Pharma all-time high annual cash & cash equivalents is $19.99 M
What is Nuvectis Pharma annual cash & cash equivalents year-on-year change?
Over the past year, NVCT annual cash & cash equivalents has changed by -$867.00 K (-4.34%)
What is Nuvectis Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NVCT is $17.17 M
What is the all time high quarterly cash and cash equivalents for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly cash and cash equivalents is $24.60 M
What is Nuvectis Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, NVCT quarterly cash and cash equivalents has changed by -$4.89 M (-22.17%)